Actively Recruiting
PENG Block & PENG PRF
Led by Ankara City Hospital Bilkent · Updated on 2026-03-18
84
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary aim of this study is to prospectively compare the effects of the pericapsular nerve group (PENG) block alone and the combination of PENG block with pulsed radiofrequency (PRF) on pain intensity in patients with chronic hip pain. As a secondary aim, the effects of both treatment modalities on hip function are intended to be evaluated using valid and reliable functional assessment scales. Through this study, it is aimed to demonstrate the clinical contribution of adding PRF to the PENG block and to identify a more effective and longer-lasting approach for the interventional treatment of chronic hip pain.
CONDITIONS
Official Title
PENG Block & PENG PRF
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chronic hip pain lasting at least 3 months
- Baseline pain score of 4 or higher on the Visual Analog Scale (VAS)
- Clinical and/or radiological diagnosis of hip osteoarthritis
- Inadequate response to conservative treatments
You will not qualify if you...
- Local or systemic infection at the intervention site
- Coagulopathy or inability to stop anticoagulant therapy
- Hip pain caused by cancer
- History of hip replacement surgery
- Severe neurological deficits
- Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye), 06680
Actively Recruiting
Research Team
U
Ulku Sabuncu MD, Assoc. prof.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here